Actively Recruiting

Phase Not Applicable
Age: 50Years - 85Years
All Genders
NCT06335992

Tissue Regeneration in Patients With Chronic Obstructive Pulmonary Disease After an Exercise Intervention.

Led by Uppsala University · Updated on 2025-08-19

80

Participants Needed

2

Research Sites

169 weeks

Total Duration

On this page

Sponsors

U

Uppsala University

Lead Sponsor

L

Lund University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The main objective of this project is to identify mechanisms for lung regeneration in patients with COPD induced by exercise training. The hypothesis is that adjusted exercise training improves disease outcome in these patients by decrease remodelling processes linked to oxidative stress, inflammatory and/or immunological pathways in the lung. Along the way, the investigator also expect to identify (or validate) biomarkers mirroring systemic processes such as reduced inflammation and ameliorating the epithelial barrier in these patients. These events may additionally act as potential targets for interventions. Objectives (i) Evaluate biomarkers for regenerative processes, matrix turnover, stem cell activity and inflammatory patterns in lung tissue biopsies, blood- and urine samples correlated to vital lung parameters and physical capacity, before and after attending an exercise-training program. (ii) Study the effects of exercise training on the pulmonary ventilation/perfusion ratio and quality of life. (iii) Evaluate the relation between pathophysiology in the lung evaluated by CT scan, and systemic response measured by muscle biopsies and biomarkers in blood/urine. (iv) Investigate in vitro cell behaviour and remodelling/regenerative processes altered in COPD patients upon exercise training (aim 1).

CONDITIONS

Official Title

Tissue Regeneration in Patients With Chronic Obstructive Pulmonary Disease After an Exercise Intervention.

Who Can Participate

Age: 50Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Forced expiratory volume in one second (FEV1) 85-30 % of predicted post bronchodilator
  • Receiving optimal medical treatment according to GOLD and the Swedish National Guidelines
  • No other significant diseases that limit physical exercise
  • Non-smoking for at least one year
  • No exacerbations in the last 4 weeks
  • Body mass index (BMI) between 18 and 35
Not Eligible

You will not qualify if you...

  • Regular participation in adjusted or specially designed exercise sessions
  • Unstable cardiovascular or pulmonary disease
  • Current smoking
  • Any other condition that prevents participation in an exercise-training program as judged by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Lund University

Lund, Sweden

Actively Recruiting

2

Uppsala University

Uppsala, Sweden

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here